abstract |
The present invention relates to novel compounds of formula (I). The compounds of the present invention are hedgehog pathway antagonists. Specifically, the compounds of the present invention are useful as Smoothened (SMO) inhibitors. The present invention also contemplates the use of compounds to treat diseases that can be treated by inhibition of the hedgehog pathway and SMO, such as cancer. |